RECURRENT RENAL CELL CARCINOMA
Clinical trials for RECURRENT RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Double-Punch combo to fight tough kidney cancer
Disease control OngoingThis study is testing whether adding an experimental immune-boosting drug (PF-04518600) to a standard cancer drug (axitinib) works better than the standard drug alone for people with advanced kidney cancer that has spread. The goal is to see if the combination can better control …
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope pill tested for kids with tough cancers
Disease control OngoingThis study is testing whether a pill called cabozantinib can help control rare cancers that have come back or stopped responding to other treatments in children and young adults. It includes patients with sarcomas, Wilms tumor, and other rare tumors. The drug aims to slow or stop…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test new Cancer-Fighting duo in early trial
Disease control OngoingThis early-stage study is testing a new combination of two existing cancer drugs, pembrolizumab and ziv-aflibercept, in patients with advanced solid tumors. The main goal is to find the safest and most effective dose of the combination. Researchers will also look for early signs …
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New blood test could spot kidney cancer sooner
Diagnosis OngoingThis study is testing a new lab test that measures certain immune cells in blood and urine to see if it can help detect kidney cancer early and monitor how it responds to treatment. Researchers are comparing results from healthy people, people with localized cancer, and people wi…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Sponsor: University of Southern California • Aim: Diagnosis
Last updated Mar 23, 2026 15:14 UTC